Qiming Star | One-Time Treatment, Long-Term Benefit: BBM-H901's First National Prescription Filled, Hemophilia B Care Enters Gene Therapy Era
This milestone breakthrough not only marks the first domestically developed innovative gene therapy becoming available to hemophilia B patients in China, but also signals that treatment for the disease in the country has officially entered an entirely new era of gene therapy.









